IR@PKUHSC  > 北京大学第二临床医学院
学科主题临床医学
Pharmacokinetics of tacrolimus converted from twice-daily formulation to once-daily formulation in Chinese stable liver transplant recipients
Zhang, Yi-fan1; Chen, Xiao-yan1; Dai, Xiao-jian1; Leng, Xi-sheng2; Zhong, Da-fang1
关键词tacrolimus modified release clinical pharmacokinetics liver transplantation
刊名ACTA PHARMACOLOGICA SINICA
2011-11-01
DOI10.1038/aps.2011.125
32期:11页:1419-1423
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Chemistry, Multidisciplinary ; Pharmacology & Pharmacy
研究领域[WOS]Chemistry ; Pharmacology & Pharmacy
关键词[WOS]MODIFIED-RELEASE TACROLIMUS ; SOLID-ORGAN TRANSPLANTATION ; PROGRAF-BASED REGIMEN ; OPEN-LABEL TRIAL ; CLINICAL-EXPERIENCE ; CONVERSION
英文摘要

Aim: To evaluate the pharmacokinetics of tacrolimus in Chinese stable liver transplant recipients converted from immediate release (IR) tacrolimus-based immunosuppression to modified release (MR) tacrolimus-based immunosuppression.

Methods: Open-label, multi-center study with a one-way conversion design was conducted. Eighty-three stable liver recipients (6-24 months post-transplant) with normal renal and stable hepatic function were converted from IR tacrolimus twice-daily treatment to MR tacrolimus once-daily treatment on a 1:1 (mg:mg) total daily dose basis. Twenty-four hour pharmacokinetic studies were carried out on d 0 (pre-conversion), d 1, and d 84 (post-conversion).

Results: The area under the blood concentration-time curve of MR tacrolimus from 0 to 24 h (AUC(0-24)) on d 1 was comparable to that of IR tacrolimus on d 0, with a 90% confidence interval (CI) for MR/IR tacrolimus of 92%-97%. The AUC(0-24) value for MR tacrolimus on d 84 with the daily dose increased by 14% was approximately 17% lower than that for IR tacrolimus. The 90% CI was 77%-90%, outside the bioequivalence range of 80%-125%. There was a good correlation between AUC(0-24) and concentration at 24 h (C(24)) for IR tacrolimus (d 0, r=0.930) and MR tacrolimus (d 1, r=0.936; d 84, r=0.903).

Conclusion: The exposure to tacrolimus when administered MR tacrolimus once daily is not equivalent to that for IR tacrolimus twice daily after an 84-day conversion in Chinese stable liver transplant recipients. The dose should be adjusted on the basis of trough levels. The therapeutic drug monitoring for patients treated with IR tacrolimus is considered to be applicable to MR tacrolimus.

语种英语
WOS记录号WOS:000296739400016
引用统计
被引频次:5[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/60994
专题北京大学第二临床医学院
北京大学第二临床医学院_中医科
作者单位1.Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China
2.Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China
推荐引用方式
GB/T 7714
Zhang, Yi-fan,Chen, Xiao-yan,Dai, Xiao-jian,et al. Pharmacokinetics of tacrolimus converted from twice-daily formulation to once-daily formulation in Chinese stable liver transplant recipients[J]. ACTA PHARMACOLOGICA SINICA,2011,32(11):1419-1423.
APA Zhang, Yi-fan,Chen, Xiao-yan,Dai, Xiao-jian,Leng, Xi-sheng,&Zhong, Da-fang.(2011).Pharmacokinetics of tacrolimus converted from twice-daily formulation to once-daily formulation in Chinese stable liver transplant recipients.ACTA PHARMACOLOGICA SINICA,32(11),1419-1423.
MLA Zhang, Yi-fan,et al."Pharmacokinetics of tacrolimus converted from twice-daily formulation to once-daily formulation in Chinese stable liver transplant recipients".ACTA PHARMACOLOGICA SINICA 32.11(2011):1419-1423.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Zhang, Yi-fan]的文章
[Chen, Xiao-yan]的文章
[Dai, Xiao-jian]的文章
百度学术
百度学术中相似的文章
[Zhang, Yi-fan]的文章
[Chen, Xiao-yan]的文章
[Dai, Xiao-jian]的文章
必应学术
必应学术中相似的文章
[Zhang, Yi-fan]的文章
[Chen, Xiao-yan]的文章
[Dai, Xiao-jian]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。